The Consortium members bring along highly complementary and relevant expertise that ensure that the complex tasks associated with the introduction of a novel approach into vaccine development is successful. Collaboration partners, including an experienced vaccine manufacturer and world class clinical testing sites are strong assets and essential elements for the efficient and successful execution of the program.